tert-Butyl 1-bromo-5,6-dihydroimidazo[1,5-a]pyrazine-7(8H)-carboxylate, 95.0%, 250mg

N-(2,4-DIBROMO-6-CYANOPHENYL)ACETAMIDE, 90.0%, 1g

2-Chloro-5-(3-thienyl)pyridine, 97.0%, 2g

(3-((Tetrahydro-2H-pyran-2-yl)oxy)phenyl)boronic acid, 95.0%, 5g

3,5-bis(trifluoromethyl)benzoylacetonitrile, 97.0%, 5g

Glycerol Dimethacrylate (mixture of 1,2- and 1,3-form) (stabilized with MEHQ)>90.0%(GC)25g

2,4-Dichloro-7,7-dimethyl-5,7-dihydrofuro[3,4-d]pyrimidine, 95.0%, 100mg

Plan strain-free PLPOLi 20x/0.40 IOS objective for iScope transmitted polarization, 0.17 mm cover glass correction. Working distance 5.1 mm

N-(2-Aminophenyl)pyrazine-2-carboxamide, 97%, 250mg

2-Bromo-4-methoxy-6-methylpyrimidine, 97%, 250mg

2-Amino-5-bromo-4-hydroxy-6-phenylpyrimidine, 95.0%, 250mg

3-[(dimethylamino)methyl]-4-methoxybenzaldehyde hydrochloride, 95.0%, 1g

2-Bromo-N,N-dimethylacetamide, 95.0%, 1g